{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:12:51Z","timestamp":1777443171561,"version":"3.51.4"},"reference-count":59,"publisher":"Bentham Science Publishers Ltd.","issue":"1","funder":[{"DOI":"10.13039\/501100003141","name":"CONACyT","doi-asserted-by":"publisher","award":["275849\/470980"],"award-info":[{"award-number":["275849\/470980"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"CONACyT","doi-asserted-by":"publisher","award":["609209\/772588"],"award-info":[{"award-number":["609209\/772588"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2019,1,7]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p> Thalidomide, the first synthesized phthalimide, has demonstrated sedative-\nhypnotic and antiepileptic effects on the central nervous system. N-substituted phthalimides\nhave an interesting chemical structure that confers important biological properties.\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p> Non-chiral (ortho and para bis-isoindoline-1,3-dione, phthaloylglycine) and chiral\nphthalimides (N-substituted with aspartate or glutamate) were synthesized and the sedative, anxiolytic\nand anticonvulsant effects were tested.\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Method:<\/jats:title>\n<jats:p> Homology modeling and molecular docking were employed to predict recognition of the\nanalogues by hNMDA and mGlu receptors. The neuropharmacological activity was tested with the\nopen field test and elevated plus maze (EPM). The compounds were tested in mouse models of\nacute convulsions induced either by pentylenetetrazol (PTZ; 90 mg\/kg) or 4-aminopyridine (4-AP;\n10 mg\/kg).\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p> The ortho and para non-chiral compounds at 562.3 and 316 mg\/kg, respectively, decreased\nlocomotor activity. Contrarily, the chiral compounds produced excitatory effects. Increased\nlocomotor activity was found with S-TGLU and R-TGLU at 100, 316 and 562.3 mg\/kg,\nand S-TASP at 316 and 562.3 mg\/kg. These molecules showed no activity in the EPM test or PTZ\nmodel. In the 4-AP model, however, S-TGLU (237.1, 316 and 421.7 mg\/kg) as well as S-TASP\nand R-TASP (316 mg\/kg) lowered the convulsive and death rate.\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p> The chiral compounds exhibited a non-competitive NMDAR antagonist profile and\nthe non-chiral molecules possessed selective sedative properties. The NMDAR exhibited stereoselectivity\nfor S-TGLU while it is not a preference for the aspartic derivatives. The results appear to\nbe supported by the in silico studies, which evidenced a high affinity of phthalimides for the\nhNMDAR and mGluR type 1.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573406414666180525082038","type":"journal-article","created":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T03:34:11Z","timestamp":1527219251000},"page":"102-118","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Neuropharmacological Screening of Chiral and Non-chiral Phthalimide- Containing Compounds in Mice: in vivo and in silico Experiments"],"prefix":"10.2174","volume":"15","author":[{"given":"Carolina","family":"Campos-Rodr\u00edguez","sequence":"first","affiliation":[{"name":"Physiology Department, Escuela Nacional de Ciencias Biologicas, Instituto Politecnico Nacional, Unidad Profesional Adolfo Lopez Mateos, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 G.","family":"Trujillo-Ferrara","sequence":"additional","affiliation":[{"name":"Medicinal Biochemistry Department, Escuela Superior de Medicina Instituto Politecnico Nacional, Unidad Profesional L\u00e1zaro Cardenas del R\u00edo, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ameyali","family":"Alvarez-Guerra","sequence":"additional","affiliation":[{"name":"Physiology Department, Escuela Nacional de Ciencias Biologicas, Instituto Politecnico Nacional, Unidad Profesional Adolfo Lopez Mateos, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ir\u00e1n M. Cumbres","family":"Vargas","sequence":"additional","affiliation":[{"name":"Physiology Department, Escuela Nacional de Ciencias Biologicas, Instituto Politecnico Nacional, Unidad Profesional Adolfo Lopez Mateos, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto I.","family":"Cuevas-Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Medicinal Biochemistry Department, Escuela Superior de Medicina Instituto Politecnico Nacional, Unidad Profesional L\u00e1zaro Cardenas del R\u00edo, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Andrade-Jorge","sequence":"additional","affiliation":[{"name":"Medicinal Biochemistry Department, Escuela Superior de Medicina Instituto Politecnico Nacional, Unidad Profesional L\u00e1zaro Cardenas del R\u00edo, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Zamudio","sequence":"additional","affiliation":[{"name":"Physiology Department, Escuela Nacional de Ciencias Biologicas, Instituto Politecnico Nacional, Unidad Profesional Adolfo Lopez Mateos, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo R.-S.","family":"Juan","sequence":"additional","affiliation":[{"name":"Physiology Department, Escuela Nacional de Ciencias Biologicas, Instituto Politecnico Nacional, Unidad Profesional Adolfo Lopez Mateos, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0968-0896(01)00308-X","volume":"10","author":"Hashimoto Y.","year":"2002","unstructured":"Hashimoto Y. Bioorgan Med Chem, Structural development of biological response modifiers based on thalidomide.,, 2002, 10,, 461-479,","journal-title":"Bioorgan Med Chem"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.biocel.2007.01.022","volume":"39","author":"Meltchert M.","year":"2007","unstructured":"Meltchert M, List A. Int J Biochem Cell B, The thalidomide saga.,, 2007, 39,, 1489-1499,","journal-title":"Int J Biochem Cell B"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/S0140-6736(04)16308-3","volume":"363","author":"Franks M.E.","year":"2004","unstructured":"Franks ME, Macpherson GR, Figg WD. Lancet, Thalidomide.,, 2004, 363,, 1802-1811,","journal-title":"Lancet"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejps.2015.12.017","volume":"83","author":"Casal J.J.","year":"2016","unstructured":"Casal JJ, Bollini M, Lombardo ML, Bruno AM. Eur J Pharm Sci, Thalidomide analogues: Tumor necrosis factor-alpha inhibitors and their evaluation as anti-inflammatory agents.,, 2016, 83,, 114-119,","journal-title":"Eur J Pharm Sci"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jns.2015.02.043","volume":"351","author":"Palencia G.","year":"2015","unstructured":"Palencia G, N\u00fa\u00f1ez-Medrano J, Ortiz-Plata A, Jim\u00e9nez-Farf\u00e1n D, Sotelos J, S\u00e1nchez A, Trejo-Sol\u00eds C. J Neurol Sci, Anti-apoptotic, anti-oxidant, and anti-inflammatory effects of thalidomide on cerebral ischemia\/reperfusion injury in rats.,, 2015, 351,, 78-87,","journal-title":"J Neurol Sci"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jns.2007.03.010","volume":"258","author":"Palencia G.","year":"2007","unstructured":"Palencia G, Calderon A, Sotelo J. J Neurol Sci, Thalidomide inhibits pentylenetetrazole-induced seizures.,, 2007, 258,, 128-131,","journal-title":"J Neurol Sci"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.yebeh.2014.03.020","volume":"34","author":"Payandemehr B.","year":"2014","unstructured":"Payandemehr B, Rahimian R, Gooshe M, Bahremand A, Gholizadeh R, Berijani S, Ahmadi-Dastegerdi M, Aminizade M, Sarreshte-Dari A, Dianati V, Amanlou M, Dehpour AR. Epilepsy Behav, Nitric oxide mediates the anticonvulsant effects of thalidomide on pentylenetetrazole-induced tonic seizures in mice.,, 2014, 34,, 99-104,","journal-title":"Epilepsy Behav"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0887-8994(03)00216-9","volume":"29","author":"Marjanovic B.D.","year":"2003","unstructured":"Marjanovic BD, Stojanov LM, Zdravkovic DS, Kravljanac RM, Djordjevic MS. Pediatr Neurol, Rasmussen syndrome and long term response to thalidomide.,, 2003, 29,, 151-156,","journal-title":"Pediatr Neurol"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.eplepsyres.2010.10.003","volume":"92","author":"Palencia G.","year":"2010","unstructured":"Palencia G, Martinez-Juarez IE, Calderon A, Artigas C, Sotelo J. Epilepsy Res, Thalidomide for treatment of refractory epilepsy.,, 2010, 92,, 253-257,","journal-title":"Epilepsy Res"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0304-3940(97)00685-X","volume":"234","author":"Boireau A.","year":"1997","unstructured":"Boireau A, Bordier F, Dub\u00e9dat P, P\u00e9ny C, Imp\u00e9rato A. Neurosci Lett, Thalidomide reduces MPTP induced decrease in striatal dopamine levels in mice.,, 1997, 234,, 123-126,","journal-title":"Neurosci Lett"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.neuroscience.2008.12.043","volume":"159","author":"Hyakkoku K.","year":"2009","unstructured":"Hyakkoku K, Nakajima Y, Izuta H, Shimazawa M. Neuroscience, Thalidomide protects against ischemic neuronal damage induced by focal cerebral ischemia in mice.,, 2009, 159,, 760-769,","journal-title":"Neuroscience"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neuro.2015.02.004","volume":"47","author":"Palencia G.","year":"2015","unstructured":"Palencia G, Garc\u00eda E, Osorio-Rico L, Trejo-Sol\u00eds C, Escamilla-Ram\u00edrez A, Sotelo J. Neurotoxicology, Neuroprotective effect of thalidomide on MPTP-induced toxicity.,, 2015, 47,, 82-87,","journal-title":"Neurotoxicology"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0014-2999(99)00918-8","volume":"391","author":"Ribeiro R.A.","year":"2000","unstructured":"Ribeiro RA, Vale ML, Ferreira SH, Cunha FQ. Eur J Pharmacol, Analgesic effect of thalidomide on inflammatory pain.,, 2000, 391,, 97-103,","journal-title":"Eur J Pharmacol"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0149-2918(03)80085-1","volume":"23","author":"Matthews S.J.","year":"2003","unstructured":"Matthews SJ, McCoy C. Clin Ther, Thalidomide: a review of approved and investigational uses.,, 2003, 23,, 342-395,","journal-title":"Clin Ther"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00044-013-0730-1","volume":"23","author":"Leite A.C.L.","year":"2014","unstructured":"Leite ACL, Barbosa FF, Cardoso MVO, Moreira DRM, Co\u00eahlo LCD, da Silva EB, Filho GBO, de Souza VMO, Pereira VRA, Reis L de C, Ferreira PMP, Pessoa C, Wanderley AG, Mota FVB, Da Silva TG. Med Chem Res, Phthaloyl amino acids as anti-inflammatory and immunomodulatory prototypes.,, 2014, 23,, 1701-1708,","journal-title":"Med Chem Res"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.pbb.2014.04.008","volume":"122","author":"Godin A.M.","year":"2014","unstructured":"Godin AM, Ara\u00fajo DP, Menezes RR, Brito AMS, Melo ISF, Coura GME, Soares DG, Bastos LFS, Amaral FA, Ribeiro LS, Boff D, Santos JRA, Santos DA, Teixeira MM, de F\u00e1tima A, Machado RR, Coelho MM. Pharmacol Biochem Behav, Activities of 2 phthalimidethanol and 2 phthalimidethyl nitrate, phthalimide analogs devoid of the glutarimide moiety, in experimental models of inflammatory pain and edema.,, 2014, 122,, 291-298,","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00726-004-0109-1","volume":"27","author":"Zeng Q.","year":"2014","unstructured":"Zeng Q, Liu Z, Li B, Wang F. Amino Acids, Mild and effective N-phthaloylation of amino acids.,, 2014, 27,, 183-186,","journal-title":"Amino Acids"},{"key":"ref=18","first-page":"1817","volume":"8","author":"Homsi A.","year":"2015","unstructured":"Homsi A, Kasideh A. Int J Chemtech Res, synthesis of some N-phthalimide amino acids derivatives and evaluation their biological activity.,, 2015, 8,, 1817-1825,","journal-title":"Int J Chemtech Res"},{"key":"ref=19","first-page":"232","volume":"427","author":"Singh G.","year":"2015","unstructured":"Singh G, Saroa A, Girdhar S, Rani S, Sahoo S, Choquesillo-Lazarte D. A Lett, Synthesis, characterization, electronic absorption and antimicrobial studies of N (silatranylpropyl)phthalimide derived from phthalic anhydride. Inorg. Chim.,, 2015, 427,, 232-239,","journal-title":"A Lett"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2016.03.003","volume":"66","author":"Ahmed H.E.A.","year":"2016","unstructured":"Ahmed HEA, Abdel-Salam HA, Shaker MA. Bioorg Chem, Synthesis, characterization, molecular modeling, and potential antimicrobial and anticancer activities of novel 2-aminoisoindoline-1,3-dione derivatives.,, 2016, 66,, 1-11,","journal-title":"Bioorg Chem"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.7324\/JAPS.2016.60330","volume":"6","author":"Kushwaha N.","year":"2016","unstructured":"Kushwaha N, Kaushik D. JAPS, Recent advances and future prospects of phthalimide derivatives.,, 2016, 6,, 159-171,","journal-title":"JAPS"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1007\/s00044-013-0870-3","volume":"23","author":"Alibadi A.","year":"2014","unstructured":"Alibadi A, Gholamine B, Karimi T. Med Chem Res, Synthesis and antiseizure evaluation of isoindoline-1,3-dione derivatives in mice.,, 2014, 23,, 2736-2743,","journal-title":"Med Chem Res"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1016\/S0960-894X(98)00558-7","volume":"8","author":"Antunes R.","year":"1998","unstructured":"Antunes R, Batista H, Srivastava RM, Thomas G, Araujo CC. Bioorg Med Chem Lett, New phthalimide derivatives with potent analgesic activity: II.,, 1998, 8,, 3071-3076,","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"e0119440","DOI":"10.1371\/journal.pone.0119440","volume":"10","author":"Kumar C.S.C.","year":"2015","unstructured":"Kumar CSC, Loh W-S, Chandraju S, Win Y-F, Tan WK, Quah CK, Fun H-K. PLoS One, Synthesis, structural and antioxidant studies of some novel N-ethyl phthalimide esters.,, 2015, 10,, e0119440-,","journal-title":"PLoS One"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1021\/jm990068t","volume":"43","author":"Vamecq J.","year":"2000","unstructured":"Vamecq J, Bac P, Herrenknecht C, Maurois P, Delcourt P, Stables JP. J Med Chem, Synthesis and anticonvulsant and neurotoxic properties of substituted N-phenyl derivatives of the phthalimide pharmacophore.,, 2000, 43,, 1311-1319,","journal-title":"J Med Chem"},{"key":"ref=26","first-page":"81","volume":"34","author":"Faghihi K.","year":"2010","unstructured":"Faghihi K, Absalar M, Hajibeygi M. Turk J Chem, Synthesis and characterization of new optically active polyamides containing 2-(4-nitro-1,3-dioxoisoindolin-2-yl)succinic acid and aromatic diamines via direct polycondensation.,, 2010, 34,, 81-90,","journal-title":"Turk J Chem"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.nrl.2011.10.014","volume":"27","author":"Flores-Soto M.E.","year":"2012","unstructured":"Flores-Soto ME, Chaparro-Huerta V, Escoto-Delgadillo M, Vazquez-Valls E, Gonzalez-Casta\u00f1eda RE, Beas-Zarate C. Neurologia, Estructura y funci\u00f3n de las subunidades del receptor a glutamato tipo NMDA.,, 2012, 27,, 301-310,","journal-title":"Neurologia"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"D115","DOI":"10.1093\/nar\/gkh131","volume":"32","author":"Apweiler R.","year":"2014","unstructured":"Apweiler R, Bairoch A, Wu CH, Barker WC, Boeckmann B, Ferro S, Gasteiger E, Huang H, Lopez R, Magrane M, Martin MJ, Natale DA, O\u2019Donovan C, Redaschi N, Yeh LS. Nucleic Acids Res, UniProt: The Universal Protein knowledgebase.,, 2014, 32,, D115-D119,","journal-title":"Nucleic Acids Res"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1126\/science.1251915","volume":"344","author":"Karakas E.","year":"2014","unstructured":"Karakas E, Furukawa H. Science, Crystal structure of a heterotetrameric NMDA receptor ion channel.,, 2014, 344,, 992-997,","journal-title":"Science"},{"key":"ref=30","author":"Eswar N.","unstructured":"Eswar N, Webb B, Marti-Renom, Ma, A.; Madhusudhan, M.S.; Eramian, D.; Shen, M.Y.; Pieper, U.; Sali, A. Comparative Protein Structure Modeling Using Modeller , Bateman, A.; Draghici, S.; Khuran, E.; Orchard, S.; Pearson, W.R., Eds.; John Wiley and Sons, Inc., New Jersey,, ,  5.6.1-5.6.30., Current Protocols in Bioinformatics, 2006,-","journal-title":"Current Protocols in Bioinformatics"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/prot.10286","volume":"50","author":"Lovell S.C.","year":"2015","unstructured":"Lovell SC, Davis IW, Arendall WB, De Bakker PIW, Word JM, Prisant MG, Richardson JS, Richardson DC. Proteins, Structure validation by C\u03b1 geometry: \u03c6,\u03c8 and C\u03b2 deviation.,, 2015, 50,, 437-450,","journal-title":"Proteins"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/978-1-4939-7465-8_5","volume":"1705","author":"Tautermann C.S.","year":"2018","unstructured":"Tautermann CS. Methods Mol Biol, GPCR Homology Model Generation for Lead Optimization.,, 2018, 1705,, 115-131,","journal-title":"Methods Mol Biol"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1249489","volume":"344","author":"Wu H.","year":"2014","unstructured":"Wu H, Wang C, Gregory KJ, Han GW, Cho HP, Xia Y, Niswender CM, Katritch V, Meiler J, Cherezov V, Conn PJ, Stevens RC. Science, Structure of a Class C GPCR Metabotropic Glutamate Receptor 1 Bound to an Allosteric Modulator.,, 2014, 344,, 58-64,","journal-title":"Science"},{"key":"ref=34","author":"Dassault Syst\u00e8mes B.I.O.V.I.A.","unstructured":"Dassault Syst\u00e8mes BIOVIA, ,  San Diego,, Dassault Syst\u00e8mes, , Discovery Studio Modeling Environment, Release 2017., 2016,-","journal-title":"Discovery Studio Modeling Environment, Release 2017"},{"key":"ref=35","author":"Frisch M.J.","unstructured":"Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Petersson GA, Nakatsuji H, Li X, Caricato M, Marenich A, Bloino J, Janesk R, Gomperts B, Mennucci B, Hratchian HP, Ortiz JV, Izmaylov AF, Sonnenberg JL, Williams-Young D, Ding F, Lipparini F, Egidi F, Goings J, Peng B, Petrone A, Henderson T, Ranasinghe D, Zakrzewski VG, Gao J, Rega N, Zheng G, Liang W, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Vreven T, Throssell K, Montgomery Jr, Peralta JE, Olgliaro F, Bearpark M, Heyd JJ, Brothers E, Kudin KN, Staroverov VN, Keith T, Kobayashi R, Normand J, Raghvachari K, Rendell A, Burant JC, Iyengar SS, Romasi J, Cossi M, Millam JM, Klene M, Adamo C, Cammi R, Ochterski W, Martin RL, Morokuma K, Farkas O, Foresman JB, Fox DJ, , Gaussian, Inc.,, Wallingford, CT, , Gaussian 09, Revision A.02., 2016,-","journal-title":"Gaussian 09, Revision A02"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"Morris G.M.","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ. J Comput Chem, AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.,, 2009, 30,, 2785-2791,","journal-title":"J Comput Chem"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nprot.2016.051","volume":"11","author":"Forli S.","year":"2016","unstructured":"Forli S, Huey R, Pique ME, Sanner MF, Goodsell DS, Olson AJ. Nat Protoc, Computational protein ligand docking and virtual drug screening with the AutoDock suite.,, 2016, 11,, 905-919,","journal-title":"Nat Protoc"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","volume":"19","author":"Morris G.M.","year":"1998","unstructured":"Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ. J Comput Chem, Automated docking using a Lamarckian Genetic Algorithm and an Empirical Binding Free Energy Function.,, 1998, 19,, 1639-1662,","journal-title":"J Comput Chem"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.nbd.2007.08.019","volume":"29","author":"Ryu J.K.","year":"2008","unstructured":"Ryu JK, McLarnon JG. Neurobiol Dis, Thalidomide inhibition of perturbed vasculature and glial-derived tumor necrosis factor- \u03b1 in an animal model of inflamed Alzheimer\u2019 s disease brain.,, 2008, 29,, 254-266,","journal-title":"Neurobiol Dis"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","volume":"463","author":"Prut L.","year":"2003","unstructured":"Prut L, Belzung C. Eur J Pharmacol, The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review.,, 2003, 463,, 3-33,","journal-title":"Eur J Pharmacol"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/ddr.20382","volume":"71","author":"Lopez-Martinez M.","year":"2010","unstructured":"Lopez-Martinez M, Salgado-Zamora H, Ramirez-San Juan E, Zamudio S, Picazo O, Campos ME, Naranjo-Rodriguez EB. Drug Develop Res, Anti-anxiety and sedative profile evaluation of imidazo[1,2-a]pyridine derivatives.,, 2010, 71,, 371-381,","journal-title":"Drug Develop Res"},{"key":"ref=42","author":"Blumstein D.T.","unstructured":", Blumstein DT, Daniel JC, Evans CS. JWatcher v.1.0. http:\/\/www.jwatcher.ucla.edu\/, , (Accessed June 21, 2017),"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nprot.2007.44","volume":"2","author":"Walf A.A.","year":"2007","unstructured":"Walf AA, Frye CA. Nat Protoc, The use of the elevated plus maze as an assay of anxiety-related behavior in rodents.,, 2007, 2,, 322-328,","journal-title":"Nat Protoc"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbr.2013.02.035","volume":"246","author":"Sorregotti T.","year":"2013","unstructured":"Sorregotti T, Mendes-Gomes J, Rico JL, Rodgers RJ, Nunes-de-Souza RL. Behav Brain Res, Ethopharmacological analysis of the open elevated plus-maze in mice.,, 2013, 246,, 76-85,","journal-title":"Behav Brain Res"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.bionut.2014.08.004","volume":"4","author":"Vinitha E.","year":"2014","unstructured":"Vinitha E, Singh HJC, Kakalij RM, Kshirsagar RP, Kumar BH, Diwan PV. Biomed Prev Nutr, Neuroprotective effect of Prunus avium on streptozotocin induced neurotoxicity in mice.,, 2014, 4,, 519-525,","journal-title":"Biomed Prev Nutr"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4103\/0975-7406.80782","volume":"3","author":"Thakur A.","year":"2011","unstructured":"Thakur A, Sahai A, Thakur J. J Pharm Bioallied Sci, Experimental re-evaluation of flunarizine as add-on antiepileptic therapy.,, 2011, 3,, 253-258,","journal-title":"J Pharm Bioallied Sci"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0920-1211(92)90016-M","volume":"11","author":"Yamaguchi S.","year":"1992","unstructured":"Yamaguchi S, Rogawski MA. Epilepsy Res, Effects of anticonvulsant drugs on 4-aminopyridine induced seizures in mice.,, 1992, 11,, 9-16,","journal-title":"Epilepsy Res"},{"key":"ref=48","first-page":"59","volume":"387","author":"Sancheti J.","year":"2014","unstructured":"Sancheti J, Shaikh MF, Chaudhari R, Somani G, Patil S, Jain P, Sathaye S. Pharmacol, Characterization of anticonvulsant and antiepileptogenic potential of thymol in various experimental models. N-S Arch.,, 2014, 387,, 59-66,","journal-title":"Pharmacol"},{"key":"ref=49","author":"Bronowska A.K.","unstructured":", Bronowska AK. Thermodynamics of ligand-protein interactions: Implications for molecular design In: Thermodynamics \u2013 Ineraction studies \u2013 solids, liquids and gases; Moreno-Pirajan J.C., Ed.; InTech, 2011. Available from: https:\/\/www.intechopen.com\/books\/ thermodynamics-interaction-studies-solids-liquids-and-gases\/ther-modynamics-of-ligand-protein-interactions-implications-for-mole-cular-design, , ,"},{"key":"ref=50","first-page":"1","volume":"17","author":"Du X.","year":"2016","unstructured":"Du X, Li Y, Xia YL, Ai SM, Liang J, Sang P, Ji XL, Liu SQ. Int J Mol Sci, Insights into protein-ligand interactions: mechanisms, models, and methods.,, 2016, 17,, 1-34,","journal-title":"Int J Mol Sci"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF01234480","volume":"54","author":"Lorke D.","year":"1983","unstructured":"Lorke D. Arch Toxicol, A new approach to practical acute toxicity testing.,, 1983, 54,, 275-287,","journal-title":"Arch Toxicol"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0091-3057(94)90506-1","volume":"48","author":"Danysz W.","year":"1994","unstructured":"Danysz W, Essmann U, Bresink I, Wilke R. Pharmacol Biochem Behav, Glutamate antagonists have different effects on spontaneous locomotor activity in rats.,, 1994, 48,, 111-118,","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0006-8993(98)01353-5","volume":"819","author":"Kim J-H.","year":"1999","unstructured":"Kim J-H, Vezina P. Brain Res, Blockade of glutamate reuptake in the rat nucleus accumbens increases locomotor activity.,, 1999, 819,, 165-169,","journal-title":"Brain Res"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.neubiorev.2010.02.004","volume":"35","author":"Langen M.","year":"2011","unstructured":"Langen M, Kas MJH, Staal WC, van Engeland H, Durston S. Neurosci Behav R, The neurobiology of repetitive behavior: Of mice\u2026.,, 2011, 35,, 345-355,","journal-title":"Neurosci Behav R"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1007\/s00213-015-3946-6","volume":"232","author":"Casta\u00f1\u00e9 A.","year":"2015","unstructured":"Casta\u00f1\u00e9 A, Santana N, Artigas F. Psychopharmacol, PCP-based mice models of schizophrenia: differential behavioral, neurochemical and cellular effects of acute and subchronic treatments.,, 2015, 232,, 4085-4097,","journal-title":"Psychopharmacol"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","volume":"50","author":"Niswender C.M.","year":"2010","unstructured":"Niswender CM, Conn PJ. Annu Rev Pharmacol Toxicol, Metabotropic glutamate receptors: physiology, pharmacology and disease.,, 2010, 50,, 295-322,","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0014-2999(92)90713-E","volume":"221","author":"Fragoso-Veloz J.","year":"1992","unstructured":"Fragoso-Veloz J, Tapia R. Eur J Pharmacol, NMDA receptor antagonists protect against seizures and wet-dog shakes induced by 4-aminopyridine.,, 1992, 221,, 275-280,","journal-title":"Eur J Pharmacol"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0024-3205(98)00445-7","volume":"63","author":"Vamecq J.","year":"1998","unstructured":"Vamecq J. Life Sci, Van derpiorten, K.; Poupaert, J.H.; Balzarin, J.; De Clercq, E.; Stables, J.P. Anticonvulsant phenytoinergic pharmacophores and anti-HIV activity-preliminary- evidence for the dual requirement of the 4-aminophthalimide plataform and the N-(1-adamantyl) substitution for antiviral properties.,, 1998, 63,, 267-274,","journal-title":"Life Sci"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0014-2999(96)00157-4","volume":"305","author":"Morales-Villagr\u00e1n A.","year":"1996","unstructured":"Morales-Villagr\u00e1n A, Ure\u00f1a-Guerero ME, Tapia R. Eur J Pharmacol, Protection by NMDA receptor antagonists against seizures induced by intracerebral administration of 4-aminopyridine.,, 1996, 305,, 87-93,","journal-title":"Eur J Pharmacol"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/162443","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T02:44:09Z","timestamp":1569120249000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/162443\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,7]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573406414666180525082038","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2017-11-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-04-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}